Beijing Succeeder Technology

Beijing Succeeder Technology Current Liabilities

The Current Liabilities of Beijing Succeeder Technology (688338.SS) as of Oct 27, 2026 is 18.73 M CNY. In the previous year, Current Liabilities was 111.94 M CNY — a change of -83.27% (lower).

Current Liabilities

18.73 MCNY

YoY

-83.27%

Last updated:

Current Liabilities of Beijing Succeeder Technology is 2025 18.73 M CNY. Current Liabilities of Beijing Succeeder Technology was 2024 111.94 M CNY. It decreases by -83.27% lower compared to the previous year.

The Beijing Succeeder Technology Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
53.20 M CNY
Jan 1, 2019
38.63 M CNY
Jan 1, 2020
52.50 M CNY
Jan 1, 2021
58.16 M CNY
Jan 1, 2022
127.84 M CNY
Jan 1, 2023
121.24 M CNY
Jan 1, 2024
111.94 M CNY
Jan 1, 2025
18.73 M CNY
The Beijing Succeeder Technology Current Liabilities history
YEARCurrent LiabilitiesYoY
18.73 MCNY-83.27%
111.94 MCNY-7.67%
121.24 MCNY-5.17%
127.84 MCNY+119.81%
58.16 MCNY+10.77%
52.50 MCNY+35.90%
38.63 MCNY-27.38%
53.20 MCNY+8.45%
49.06 MCNY+32.39%
37.05 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Beijing Succeeder Technology Stock analysis

What does Beijing Succeeder Technology do? Beijing Succeeder Technology Inc generates revenue through the research, development, production, and sales of detection instruments, reagents, and consumables for thrombosis and hemostasis in the in-vitro diagnosis field. The company provides medical institutions with automated detection equipment for blood coagulation, blood rheology, hematocrit, and platelet aggregation, along with supporting reagents and consumables. Its product portfolio includes automatic coagulation testers, coagulation quality control kits, Newtonian fluid quality controls, reaction cups, and SAW blood rheology special cleaning. The firm serves domestic and overseas markets with these offerings. The company's primary customers are medical institutions that require automated detection systems for blood-related diagnostics. Products like automatic coagulation testers and coagulation quality control kits are sold to these institutions for use in clinical settings. Reagents and consumables such as Newtonian fluid quality controls and reaction cups form recurring revenue streams through regular purchases. SAW blood rheology special cleaning is also part of the consumable product line sold to the same customer segment. Beijing Succeeder Technology Inc focuses on the in-vitro diagnosis sector, specifically targeting thrombosis and hemostasis detection. The firm's products are designed to meet the needs of medical institutions for accurate and efficient blood-related diagnostic testing. By offering a comprehensive range of instruments, reagents, and consumables, the company ensures ongoing customer engagement and repeat business through essential daily supplies. Beijing Succeeder Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Beijing Succeeder Technology stock

Current Liabilities of Beijing Succeeder Technology is 18.73 M CNY in 2025.

Current Liabilities of Beijing Succeeder Technology changed from 111.94 M CNY to 18.73 M CNY, representing a -83.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Beijing Succeeder Technology since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Beijing Succeeder Technology historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Beijing Succeeder Technology

All Key Metrics — Beijing Succeeder Technology